According to the European Cancer Organization, France is behind in screening for cancers, particularly breast and colorectal, despite good results in the treatment of these diseases.
The report published on May 13 compares cancer policies in the EU. He emphasizes that France excels in the treatment of cancers, with a five-year survival rate of 87% for breast cancer and up to 93% for prostate cancer, exceeding the European average.
However, France is behind in terms of prevention and screening. Although it exceeds the European average for uterine cancer (58.8% against 56%), it lags behind for breast cancer (46.9% against 54%) and colorectal cancer (34. 6% versus 36%).
The study emphasizes the importance of screening campaigns, citing Belgium as an example for early detection of colorectal cancer. It also highlights the high rate of daily smokers in France (25.3% compared to 18.8% in Europe) and alcohol consumption (10.5 liters per adult per year compared to 10 liters in Europe). In addition, vaccination coverage against HPV, which causes cervical cancer, is insufficient in France, with a rate of 42% for girls aged 9 to 14, far from the European objective of 90%.
Finally, the report recommends combating medical deserts and improving access to health professionals. France has half as many doctors per capita as Sweden or Greece, and fewer nurses and oncologists per capita than the European average.
 Sophie de Duiéry
|
14/05/2024 | 
